The Drug Dealer Simulator series faces an influx of negative reviews on Steam, largely due to a copyright infringement accusation against Schedule 1. This controversy has sparked backlash among fans of the recent game release. While the original Drug Dealer Simulator maintains a positive rating overall, negative feedback is mounting, prompting fans to accuse Movie Games S.A. of unfair practices.

The Drug Dealer Simulator franchise, developed by Byterunners and released in 2020 and 2024, has not achieved the same popularity as Schedule 1, which launched on March 24, drawing consistent high player engagement. This situation has resulted in both games experiencing a notable decline in user rating percentages.

Negative reviews highlight frustrations over perceived bullying tactics from Movie Games S.A. against the independent development team of Schedule 1, suggesting it is hypocritical for a company to pursue legal action against an indie project following its success. Comparisons have been made to prior legal challenges faced by various developers, such as Nintendo’s actions against another studio related to copyright issues, which have also spurred criticism from the gaming community.